BioSpace News Archive

exoSTING is engineered to provide targeted delivery of Codiak’s proprietary STING agonist to antigen presenting cells in the tumor microenvironment

Korro Bio strengthens board of directors with appointment of industry leader, Omar Khwaja, M.D., Ph.D.

BIAL Biotech to be based in Cambridge, Massachusetts and will be a Research Center of Excellence dedicated to genetically-defined Parkinson’s disease

Sage Therapeutics, Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, announced the addition of Barry Greene to the company’s board of directors.

BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has signed an exclusive License and Supply Agreement with a European partner for a new product in the women’s health market for Canada. The product has been approved for sale in Canada, the U.S.A., Europe and in several other markets around the world. BioSyent intends to launch the product to the Canadian market in Q2 2021. “We

RapidAI, the worldwide leader in advanced imaging for stroke, today announced Rapid LVO is among the first software products to qualify for the New Technology Add-on Payment (NTAP).

SurGenTec, a privately held spine and orthopedic technology company dedicated to creating safe and intuitive solutions for surgeons and patients, announced today that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 3D GraftRasp System, as well as key spine indications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201001005710

The Company Substantially Exceeds its Previous Quarterly Record, of $62,864.06 in E-Commerce Sales, Reported During its 1 st Fiscal Quarter 2021 (Period: April 1 -- June 30, 2020) NEW YORK, NY, Oct. 01, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Be

Boston Scientific Corporation (NYSE: BSX) will webcast an investor update at the virtual 2020 Transcatheter Cardiovascular Therapeutics (TCT) on Thursday, October 15 from 1:00 – 2:00 p.m. EDT . Joe Fitzgerald , executive vice president and president, Interventional Cardiology; Michael Jaff , D.O., vice president and chief m

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced the release of the final local coverage determination by Palmetto MolDx for AlloSure Heart. AlloSure Heart is a donor-derived cell-free DNA (dd-cfDNA) test which can identify underlying cell inj